01 / Vendor Profile
RESEARCH AND DIAGNOSTIC SYSTEMS, INC. Federal Contracts and Awards
UEI WAYSQU5HJYT9 · CAGE 6S541
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $2.20M in net contract obligations to RESEARCH AND DIAGNOSTIC SYSTEMS, INC. across 127 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
RESEARCH AND DIAGNOSTIC SYSTEMS, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$0
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $519.2K | 44 | 3 | — |
| FY 2021 | $1.09M | 30 | 5 | +109.2% |
| FY 2022 | $279.9K | 27 | 3 | −74.2% |
| FY 2023 | $133.1K | 11 | 1 | −52.4% |
| FY 2024 | $89.5K | 8 | 1 | −32.8% |
| FY 2025 | $87.9K | 6 | 2 | −1.7% |
| FY 2026 | -$0 | 1 | 1 | −100.0% |
04 / Federal Customers
Which federal agencies buy from RESEARCH AND DIAGNOSTIC SYSTEMS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $1.97M | 107 | 89.7% | |
| 7523 | $113.3K | 4 | 5.2% | |
| 1406 | $70.4K | 1 | 3.2% | |
| 97HW | $25.9K | 1 | 1.2% | |
| 3600 | $16.2K | 1 | 0.7% | |
| 1700 | $1.3K | 6 | 0.1% | |
| 7526 | $0 | 7 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from RESEARCH AND DIAGNOSTIC SYSTEMS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $608.5K | 11 | 27.7% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $458.1K | 31 | 20.9% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $274.2K | 14 | 12.5% | |
| 75N900 | NATIONAL INSTITUTES OF HEALTH | $168.7K | 16 | 7.7% | |
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $128.8K | 3 | 5.9% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $113.3K | 4 | 5.2% | |
| 75N940 | NATIONAL INSTITUTES OF HEALTH | $92.2K | 12 | 4.2% | |
| 75N95C | NATIONAL INSTITUTES OF HEALTH | $75.2K | 5 | 3.4% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $70.9K | 7 | 3.2% | |
| 140D04 | DEPARTMENTAL OFFICES | $70.4K | 1 | 3.2% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $1.37M | 69 | 4 | 62.4% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $273.0K | 23 | 2 | 12.4% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $199.1K | 11 | 2 | 9.1% |
| 541380 | TESTING LABORATORIES | $141.0K | 7 | 1 | 6.4% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $74.1K | 4 | 2 | 3.4% |
| 541690 | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES | $61.7K | 1 | 1 | 2.8% |
| 339114 | DENTAL EQUIPMENT AND SUPPLIES MANUFACTURING | $45.5K | 3 | 1 | 2.1% |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $30.0K | 1 | 1 | 1.4% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $9.0K | 4 | 1 | 0.4% |
| 325998 | ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING | -$180 | 1 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6505 | DRUGS AND BIOLOGICALS | $714.6K | 47 | 3 | 32.5% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $666.7K | 15 | 3 | 30.4% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $406.8K | 29 | 5 | 18.5% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | $172.7K | 15 | 1 | 7.9% |
| 6810 | CHEMICALS | $151.9K | 10 | 1 | 6.9% |
| Q301 | MEDICAL- LABORATORY TESTING | $77.2K | 6 | 1 | 3.5% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $6.1K | 5 | 1 | 0.3% |
08 / Competition Pattern
How was RESEARCH AND DIAGNOSTIC SYSTEMS, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for RESEARCH AND DIAGNOSTIC SYSTEMS, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N90020P00390 | Apr 2, 2026 | -$0 | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH - CC | 339114 | 6640 |
10 / Interpreting the Profile
How should you evaluate RESEARCH AND DIAGNOSTIC SYSTEMS, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.